Skip to content

A Virtual Ward to Reduce Readmissions After Hospital Discharge

A Virtual Ward to Reduce Readmissions After Hospital Discharge

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01108172
Enrollment
1928
Registered
2010-04-21
Start date
2010-06-30
Completion date
2014-06-30
Last updated
2013-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Disease

Brief summary

The purpose of this study is to see whether a Virtual Ward reduces readmissions after hospital discharge.

Detailed description

We will conduct a pragmatic, randomized controlled trial to evaluate a new model of care for high-risk medical patients after discharge from hospital. This new model of care has two key elements. First, we will use the LACE index (see citation below for details) to identify patients who are at high risk of readmission or death after hospital discharge. These patients will be randomized to either the Virtual Ward or usual care on the day of discharge. Although patients being cared for in the Virtual Ward will reside at home, they will benefit from a hospital-like interdisciplinary team, a shared set of notes, a single point of contact, round-the-clock physician availability and increased co-ordination of specialist, primary and home-based community care for several weeks after hospital discharge.

Interventions

A multidisciplinary team to optimize medical and social care for patients residing in their own homes

OTHERUsual care

The usual care provided to patients after discharge from hospital

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Toronto Central Local Health Integration Network
CollaboratorUNKNOWN
Ontario Ministry of Health and Long Term Care
CollaboratorOTHER_GOV
Toronto Central Community Care Access Centre
CollaboratorOTHER
Women's College Hospital
CollaboratorOTHER
University Health Network, Toronto
CollaboratorOTHER
Sunnybrook Health Sciences Centre
CollaboratorOTHER
Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Discharge from medical service * LACE score greater than or equal to 10 * Age greater than or equal or 18 * Resident in Toronto Central Local Health Integration Network catchment area * Patient or designate able to speak English well enough for follow up telephone calls

Exclusion criteria

* Previously enrolled in study * Discharged to a rehabilitation or complex continuing care facility

Design outcomes

Primary

MeasureTime frameDescription
Composite of readmission to hospital or death.30 days after hospital dischargeA binary outcome variable for each patient, representing either readmission to hospital or death within 30 days of hospital discharge. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences.

Secondary

MeasureTime frameDescription
Emergency department visits30 days after dischargeA binary outcome variable for each patient, representing an emergency department visit within the time periods noted above. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences.
Long-term care admission30 days after dischargeA binary outcome variable for each patient, representing a long-term care admission within the time periods noted above. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences.
Composite of readmission or death90 days after dischargeA binary outcome variable for each patient, representing either readmission to hospital or death within the time periods noted above. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences.
Composite of readmission to hospital or death.One year after dischargeTime to the composite outcome of either readmission to hospital or death. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Data will be censored on the date of the last follow up (i.e., 30 days, 90 days or 6 months). Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences.
ReadmissionOne year after dischargeTime to readmission to hospital. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Data will be censored on the date of the last follow up (i.e., 30 days, 90 days or 6 months), or on death. Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences.
Death90 days after dischargeA binary outcome variable for each patient, representing death within the time periods noted above. A research assistant blinded to the assignment will ascertain this information via telephone using a standardized script. Second, we may also ascertain this information by linking the data we collect to administrative databases housed at the Institute for Clinical Evaluative Sciences

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026